PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY SERVICE
• Market segmentation by service
• Comparison by service
• CMO – Market size and forecast 2018-2023
• CRO – Market size and forecast 2018-2023
• Market opportunity by service
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Boehringer Ingelheim International GmbH
• Catalent, Inc
• IQVIA
• Lonza
• Thermo Fisher Scientific Inc.
PART 13: APPENDIX
• Research methodology
• List of abbreviations
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ billions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Service – Market share 2018-2023 (%)
Exhibit 18: Comparison by service
Exhibit 19: CMO – Market size and forecast 2018-2023 ($ billions)
Exhibit 20: CMO – Year-over-year growth 2019-2023 (%)
Exhibit 21: CRO – Market size and forecast 2018-2023 ($ billions)
Exhibit 22: CRO – Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by service
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America – Market size and forecast 2018-2023 ($ billions)
Exhibit 28: North America – Year-over-year growth 2019-2023 (%)
Exhibit 29: Top 3 countries in North America
Exhibit 30: Asia – Market size and forecast 2018-2023 ($ billions)
Exhibit 31: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in Asia
Exhibit 33: Europe – Market size and forecast 2018-2023 ($ billions)
Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: ROW – Market size and forecast 2018-2023 ($ billions)
Exhibit 37: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in ROW
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Boehringer Ingelheim International GmbH – Vendor overview
Exhibit 48: Boehringer Ingelheim International GmbH – Business segments
Exhibit 49: Boehringer Ingelheim International GmbH – Organizational developments
Exhibit 50: Boehringer Ingelheim International GmbH – Geographic focus
Exhibit 51: Boehringer Ingelheim International GmbH – Segment focus
Exhibit 52: Boehringer Ingelheim International GmbH – Key offerings
Exhibit 53: Boehringer Ingelheim International GmbH – Key customers
Exhibit 54: Catalent, Inc – Vendor overview
Exhibit 55: Catalent, Inc – Business segments
Exhibit 56: Catalent, Inc – Organizational developments
Exhibit 57: Catalent, Inc – Geographic focus
Exhibit 58: Catalent, Inc – Segment focus
Exhibit 59: Catalent, Inc – Key offerings
Exhibit 60: Catalent, Inc – Key customers
Exhibit 61: IQVIA – Vendor overview
Exhibit 62: IQVIA – Business segments
Exhibit 63: IQVIA – Organizational developments
Exhibit 64: IQVIA – Geographic focus
Exhibit 65: IQVIA – Segment focus
Exhibit 66: IQVIA – Key offerings
Exhibit 67: IQVIA – Key customers
Exhibit 68: Lonza – Vendor overview
Exhibit 69: Lonza – Business segments
Exhibit 70: Lonza – Organizational developments
Exhibit 71: Lonza – Geographic focus
Exhibit 72: Lonza – Segment focus
Exhibit 73: Lonza – Key offerings
Exhibit 74: Lonza – Key customers
Exhibit 75: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 76: Thermo Fisher Scientific Inc. – Business segments
Exhibit 77: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 78: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 79: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 80: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 81: Thermo Fisher Scientific Inc. – Key customers
Exhibit 82: Validation techniques employed for market sizing
【掲載企業】
Boehringer Ingelheim International GmbH, Catalent, Inc, IQVIA, Lonza, Thermo Fisher Scientific Inc.
【免責事項】
https://www.globalresearch.jp/disclaimer